Skip to content
Excelsior
About Excelsior Medical
Enterprise Spirit
Development Strategy
Related Company
Overseas Business
Company History
Product Description
Hemodialysis / Plasma Exchange
Blood Bag
Artificial Stoma
Health Appliances
ESG
Investors
Enterprise Recruitment
Contact Us
繁體中文
Investors
Investor Zone
Material Information
Board of Directors
Financial Information
Monthly Revenue
Financial Statements
Shareholder Services
Shareholders’ Meeting
Institutional Investor Conference
Dividend
Stock Quotes
Stock Transfer Agent and Registrar
Contacts
Stakeholders
Investor
Material Information
The Board of Directors release the prohibition on managers from participation in competition businesses.
2024-05-10
The Board of Directors approved Q1 2024 consolidated financial statements.
2024-05-10
Announcement for the Board meeting date of the First Quarter 2024 Financial Report
2024-05-02
The Company is invited to attend an institutional investor conference hosted by President Securities on March 27, 2024.
2024-03-26
Announcement of the resolution by the Company for the ex-dividend record date of cash dividends.
2024-03-18
The Board of Directors approved 2023 consolidated financial statements.
2024-03-08
The Board of Directors release the prohibition on managers from participation in competition businesses.
2024-03-08
The Board of Directors approved new shares for capital increase by earnings recapitalization.
2024-03-08
The Board of Directors approved dividend distribution
2024-03-08
The Board of Directors approved the convening of the 2024 Annual Shareholders’ Meeting.
2024-03-08
